# US 2024/0181124 A1 · Compositions comprising porous microparticles and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0181124 A1
- Document ID: US20240181124A1
- Status: Published application
- Kind: A1
- Application number: 18/525,295
- Filed: 2023-11-30
- Published: 2024-06-06
- Earliest claimed: 2022-12-01
- Assignees: West Chester University
- Applicants: West Chester University
- Inventors: Kurt W. Kolasinski
- Web page: https://patentgrep.com/patent/US20240181124A1

## CPC

- A61L 26/0004: {containing inorganic materials}
- A61L 26/0066: {Medicaments; Biocides}
- A61L 2300/104: Silver, e.g. silver sulfadiazine
- A61L 2300/406: Antibiotics
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present invention relates to compositions comprising microparticles and methods of using the same. Provided are compositions comprising a nanostructured material with tortuous pores. Also provided are compositions comprising a nanostructured material comprising metal. Pharmaceutical compositions comprising the compositions disclosed herein are also disclosed. The compositions and pharmaceutical compositions disclosed herein enhance wound healing properties of solutions, dispersions, creams, gels, or dressings applied to wounds. Also provided are methods of using the disclosed compositions and pharmaceutical compositions.

## Claims

### Claim 1

A composition comprising a solid substrate comprising silicon greater than about 90% in weight relative to total weight of the solid substrate and greater than about 0.1% weight in oxygen relative to the total weight of the solid substrate;
wherein the solid substrate is in the form of a microparticle comprising an exterior surface and one or a plurality of pores defining one or a plurality of interior surfaces;
wherein the solid substrate is no more than about 500 microns at its greatest length; and wherein at least about 50% of the exterior surface comprises protrusions or asperities and/or a relative roughness of about 1% to about 10% of its exterior surface.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the exterior surface comprises a metal.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the metal is adhered onto the exterior surface in the form of nanoparticles.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the metal is copper, silver, gold, platinum or palladium.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the solid substrate comprises silicon at about 98% in weight relative to total weight of the solid substrate.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the solid substrate comprises silicon at about 99% in weight relative to total weight of the solid substrate and wherein the exterior surface comprises nanoparticles of metal.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the exterior surface comprises a region of hydrophilicity.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the solid substrate in an aqueous solution has a zeta potential from about +20 to about +80 mV.

### Claim 9 (depends on 7)

The composition of claim 7, wherein the region of hydrophilicity across the exterior surface comprises polar adsorbates.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The composition of claim 1, wherein the solid substrate is in powdered form.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The composition of claim 1, wherein the microparticle Brunauer, Emmett, Teller (BET) comprises a surface area of from about 20 to about 900 centimeters squared per gram.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the microparticle: (a) is pseudo-rectangular in shape and comprises a longest dimension in length from about 1 to about 75 microns, (b) has a longest dimension across of about 7.5 microns; (c) comprises a height of an asperity comprising more than about 5% of the longest length; (d) comprises copper and a weight to weight ratio copper to silicon of from about 0.1 to about 7.0%; or (e) comprises a pore volume of from about 0.05 to about 1.9 cm3 per gram of mass of the microparticle.

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The composition of claim 1, wherein the ratio of height to length at longest dimension of the microparticle is from about 1:4 to about 1:20.

### Claim at position 17

17-18. (canceled)

### Claim 19 (depends on 1)

The composition of claim 1, wherein the exterior surface of the microparticle is bound to a therapeutic agent.

### Claim 20 (depends on 1)

A pharmaceutical composition comprising: (i) the composition of claim 1; and (ii) a pharmaceutically acceptable carrier.

### Claim 21 (depends on 20)

The pharmaceutical composition of claim 20, wherein the composition is in a solid dosage form or a liquid dosage form; and wherein the solid substrate is at a weight from about 0.1% to about 5.0% weight to weight ratio of the solid substrate to total weight of the pharmaceutical composition.

### Claim 22 (depends on 20)

A method of treating a bacterial infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 20.

### Claim 23

(canceled)

### Claim 24 (depends on 20)

A method of enhancing or accelerating wound healing in a subject in need thereof comprising exposing the pharmaceutical composition of claim 20 to a wound in the subject.

### Claim 25 (depends on 20)

A method of treating dermatitis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 20.

### Claim 26 (depends on 1)

A method of making the composition of claim 1 comprising etching a composition of silicon with an initial amount of a first oxidant reactive with silicon.

### Claim at position 26

27-33. (canceled)
